0002109817 2025-12-01 2026-08-31 0002109817 2026-08-31 0002109817 2026-10-07 0002109817 2025-11-30 0002109817 2026-06-01 2026-08-31 0002109817 us-gaap:CommonStockMember 2025-11-30 0002109817 fil:StockIssuableValueMember 2025-11-30 0002109817 us-gaap:AdditionalPaidInCapitalMember 2025-11-30 0002109817 us-gaap:RetainedEarningsMember 2025-11-30 0002109817 2025-12-01 2026-02-28 0002109817 us-gaap:CommonStockMember 2025-12-01 2026-02-28 0002109817 fil:StockIssuableValueMember 2025-12-01 2026-02-28 0002109817 us-gaap:AdditionalPaidInCapitalMember 2025-12-01 2026-02-28 0002109817 us-gaap:RetainedEarningsMember 2025-12-01 2026-02-28 0002109817 2026-02-28 0002109817 us-gaap:CommonStockMember 2026-02-28 0002109817 fil:StockIssuableValueMember 2026-02-28 0002109817 us-gaap:AdditionalPaidInCapitalMember 2026-02-28 0002109817 us-gaap:RetainedEarningsMember 2026-02-28 0002109817 2026-03-01 2026-05-31 0002109817 us-gaap:CommonStockMember 2026-03-01 2026-05-31 0002109817 fil:StockIssuableValueMember 2026-03-01 2026-05-31 0002109817 us-gaap:AdditionalPaidInCapitalMember 2026-03-01 2026-05-31 0002109817 us-gaap:RetainedEarningsMember 2026-03-01 2026-05-31 0002109817 2026-05-31 0002109817 us-gaap:CommonStockMember 2026-05-31 0002109817 fil:StockIssuableValueMember 2026-05-31 0002109817 us-gaap:AdditionalPaidInCapitalMember 2026-05-31 0002109817 us-gaap:RetainedEarningsMember 2026-05-31 0002109817 us-gaap:CommonStockMember 2026-06-01 2026-08-31 0002109817 fil:StockIssuableValueMember 2026-06-01 2026-08-31 0002109817 us-gaap:AdditionalPaidInCapitalMember 2026-06-01 2026-08-31 0002109817 us-gaap:RetainedEarningsMember 2026-06-01 2026-08-31 0002109817 us-gaap:CommonStockMember 2026-08-31 0002109817 fil:StockIssuableValueMember 2026-08-31 0002109817 us-gaap:AdditionalPaidInCapitalMember 2026-08-31 0002109817 us-gaap:RetainedEarningsMember 2026-08-31 iso4217:USD shares iso4217:USD shares 0002109817 --11-30 false 2026 Q3 10-Q true 2026-08-31 false 333-294525 MobbQuest Inc. WY 39-3278864 39 Wyandotte Avenue Oceanport NJ 07757 848 500-0715 No Yes Non-accelerated Filer true true false false 45159070

3621

48283

496

4117

48283

4117

48283

300

0.0001

46000000

45159070

4516

36828 59368

54852

-92079

-11385

4117

47983

4117

48283

635

6910

14433

73349

15068

80259

-15068

-80259

185

436

-185

-436

-15253

-80695

-15253

-80695

44171483

-0

59368

-11384

47983

0 0 36829 0 0 36829 0 0 -59368 0 0 -59368

45159070

4516

54852

59368

-35630

45159070

4516

36828

54852

-47013

49182

-29812

45159070

4516

36828

54852

-76825

19370

-15253

45159070

4516

36828

54852

-92078

4117

-80695

496

-299

-81490

22541

4516

54852

36827

-44663

48284

3621

Note 1 - Organization and Business Operation MobbQuest, Inc (the “Company”) is in the Health and Technology industry, maintains offices at 39 Wyandotte Avenue Oceanport NJ 07757, was incorporated in the state of Wyoming and commenced operation on July 17, 2025.

Note 2 - Basis of Presentation The accompanying financial /statements, which exclusively represent the operations of the Company through August 31, 2026, and disclosures regarding certain activities up to and including the years then ended, have been prepared on the accrual basis in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The accompanying financial statements reflect all adjustments including normal recurring adjustments, which, in the opinion of management, are necessary to present fairly the financial position, results of operations, and cash flows for the periods presented in accordance with GAAP. References to GAAP issued by the Financial Accounting Standards Board’s (“FASB”) in these accompanying notes to the financial statements are to the FASB Accounting Standards Codification (“ASC”).

Note 3 - Summary of Significant Accounting Policies The summary of significant accounting policies presented as follows represents those of the business as applicable for the periods presented herein and through the inception date. Use of Estimates The preparation of the Company financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the financial statements and accompanying notes thereto. The Company most significant estimates and assumptions are related to impairment assessments and loss contingencies. The company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Accordingly, actual results could differ from those estimates. Liquidity and Going Concern The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has shareholders’ equity of $4,117 for the period ended August 31, 2026 and an accumulated deficit of $92,079 as of August 31, 2026. The Company has not yet generated revenue from operations and has funded its activities to date primarily through the issuance of common stock and additional paid-in capital. The Company has incurred recurring losses from operations. For the nine months ended August 31, 2026, the Company incurred a net loss of $80,695 and used $81,490 of cash in operating activities. As of August 31, 2026, the Company had cash and cash equivalents of $3,621. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these financial statements are issued. Management has evaluated these conditions and plans to raise additional capital through the issuance of equity or debt securities and to continue efforts to generate revenue in the future. Although management believes its plans, if achieved, may mitigate the conditions raising substantial doubt, there can be no assurance that management will be successful in raising additional capital on terms acceptable to the Company, or at all. As a result, management has concluded that substantial doubt about the Company’s ability to continue as a going concern for one year from the date these financial statements are issued has not been alleviated. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Cash and Cash Equivalents The Company consider liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company continually monitor its positions with, and the credit quality of, the financial institutions with which it invests. As of the balance sheet dates, and periodically throughout the years, we have maintained balances in various operating accounts less than federally insured limits. As of August 31, 2026 and November 30, 2025, the Company had a balance of $3,621 and $48,283, respectively. Fair Value of Financial Instruments ASC 820, Fair Value Measurements and Disclosures (“ASC 820”) defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Under this guidance, the Company is required to classify certain assets and liabilities based on the fair value hierarchy, which groups fair value-measured assets and liabilities based upon the following levels of inputs: Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2 - Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; Level 3 - Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity). The fair value of financial instruments is the amount at which the instrument could be exchanged in a current transaction between willing parties. The carrying values of financial instruments such as accounts receivable, accounts payable and accrued expenses approximate fair value due to short-term nature of these instruments. Recent Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), which modifies lease accounting for lessees to increase transparency and comparability by recording lease assets and liabilities for operating leases and disclosing key information about leasing arrangements. In July 2018, the FASB issued ASU No. 2018-10, Codification Improvements to Topic 842, Leases, and ASU No. 2018-11, Leases (Topic 842), Targeted Improvements, which affect certain aspects of the previously issued guidance. In December 2018, the FASB issued ASU No. 2018-20, Narrow- Scope Improvements for Lessor, Leases (Topic 842), which provides guidance on sales tax and other taxes collected from lessees. In December 2019, the FASB issued ASU No. 2019-01, Codification Improvements to Topic 842, Leases, which affect certain aspects of the previously issued guidance. Amendments include an additional transition method that allows entities to apply the new standard on the adoption date and recognize a cumulative effect adjustment to the opening balance of retained earnings, as well as a new practical expedient for lessors. As of the adoption of Topic 842 there was no material impact. In October 2021, the FASB issued ASU No. 2021-08, “Accounting for Contract Assets and Contract Liabilities from Contracts with Customers” (Topic 805). This ASU requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities (deferred revenue) from acquired contracts using the revenue recognition guidance in Topic 606. At the acquisition date, the acquirer applies the revenue model as if it had originated the acquired contracts. For the Company, the new guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Adoption of the ASU should be applied prospectively. Early adoption is also permitted, including adoption in an interim period. The Company is currently evaluating the impact of this accounting standard update on its financial statements. Legal and Other Contingencies From time to time, the Company may be a party to litigation and subject to claims incident to the ordinary course of business, including intellectual property claims, labor and employment claims, breach of contract claims and other asserted and unasserted claims. The Company investigates these claims as they arise and will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. The accrual for a litigation loss contingency might include, for example, estimates of potential damages, outside legal fees and other directly related costs expected to be incurred. Income Taxes The Company had a total net loss for the 2025 year end, therefore there is no tax owed.

Use of Estimates The preparation of the Company financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the financial statements and accompanying notes thereto. The Company most significant estimates and assumptions are related to impairment assessments and loss contingencies. The company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Accordingly, actual results could differ from those estimates.

Liquidity and Going Concern The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has shareholders’ equity of $4,117 for the period ended August 31, 2026 and an accumulated deficit of $92,079 as of August 31, 2026. The Company has not yet generated revenue from operations and has funded its activities to date primarily through the issuance of common stock and additional paid-in capital. The Company has incurred recurring losses from operations. For the nine months ended August 31, 2026, the Company incurred a net loss of $80,695 and used $81,490 of cash in operating activities. As of August 31, 2026, the Company had cash and cash equivalents of $3,621. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these financial statements are issued. Management has evaluated these conditions and plans to raise additional capital through the issuance of equity or debt securities and to continue efforts to generate revenue in the future. Although management believes its plans, if achieved, may mitigate the conditions raising substantial doubt, there can be no assurance that management will be successful in raising additional capital on terms acceptable to the Company, or at all. As a result, management has concluded that substantial doubt about the Company’s ability to continue as a going concern for one year from the date these financial statements are issued has not been alleviated. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

4117

-92079

-80695

-81490

3621

Cash and Cash Equivalents The Company consider liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company continually monitor its positions with, and the credit quality of, the financial institutions with which it invests. As of the balance sheet dates, and periodically throughout the years, we have maintained balances in various operating accounts less than federally insured limits. As of August 31, 2026 and November 30, 2025, the Company had a balance of $3,621 and $48,283, respectively.

3621

48283

Fair Value of Financial Instruments ASC 820, Fair Value Measurements and Disclosures (“ASC 820”) defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Under this guidance, the Company is required to classify certain assets and liabilities based on the fair value hierarchy, which groups fair value-measured assets and liabilities based upon the following levels of inputs: Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2 - Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; Level 3 - Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity). The fair value of financial instruments is the amount at which the instrument could be exchanged in a current transaction between willing parties. The carrying values of financial instruments such as accounts receivable, accounts payable and accrued expenses approximate fair value due to short-term nature of these instruments.

Recent Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), which modifies lease accounting for lessees to increase transparency and comparability by recording lease assets and liabilities for operating leases and disclosing key information about leasing arrangements. In July 2018, the FASB issued ASU No. 2018-10, Codification Improvements to Topic 842, Leases, and ASU No. 2018-11, Leases (Topic 842), Targeted Improvements, which affect certain aspects of the previously issued guidance. In December 2018, the FASB issued ASU No. 2018-20, Narrow- Scope Improvements for Lessor, Leases (Topic 842), which provides guidance on sales tax and other taxes collected from lessees. In December 2019, the FASB issued ASU No. 2019-01, Codification Improvements to Topic 842, Leases, which affect certain aspects of the previously issued guidance. Amendments include an additional transition method that allows entities to apply the new standard on the adoption date and recognize a cumulative effect adjustment to the opening balance of retained earnings, as well as a new practical expedient for lessors. As of the adoption of Topic 842 there was no material impact. In October 2021, the FASB issued ASU No. 2021-08, “Accounting for Contract Assets and Contract Liabilities from Contracts with Customers” (Topic 805). This ASU requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities (deferred revenue) from acquired contracts using the revenue recognition guidance in Topic 606. At the acquisition date, the acquirer applies the revenue model as if it had originated the acquired contracts. For the Company, the new guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Adoption of the ASU should be applied prospectively. Early adoption is also permitted, including adoption in an interim period. The Company is currently evaluating the impact of this accounting standard update on its financial statements.

Legal and Other Contingencies From time to time, the Company may be a party to litigation and subject to claims incident to the ordinary course of business, including intellectual property claims, labor and employment claims, breach of contract claims and other asserted and unasserted claims. The Company investigates these claims as they arise and will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. The accrual for a litigation loss contingency might include, for example, estimates of potential damages, outside legal fees and other directly related costs expected to be incurred.

Income Taxes The Company had a total net loss for the 2025 year end, therefore there is no tax owed.

Note 4 - Supplemental Balance Sheet Disclosures Inventory Inventory consists of smart bracelet like devices that is to be sold as revenue. It is valued at $496.

496

Note 5 - Commitment and Contingencies Leases As discussed in Note 2 above, the Company adopted ASU No. 2016-02, the Company has no current lease contract. Contingencies The Company has no outstanding litigation against it.

Note 6 - Shareholders’ (Deficit) Equity The Company is authorized to issue 46,000,000 common shares with $0.0001 par value. As of August 31, 2026 the Company has 45,159,070 common shares issued and 368,275 shares issuable.

46000000

0.0001

45159070

368275

Note 7 - Taxes The Company had a total net loss for the 2025 year end and no revenue for year to date, therefore there is no tax owed.

Note 8 - Subsequent Events In accordance with SFAS 165 (ASC 85510) management has performed an evaluation of subsequent events through October 7, 2026, the date the financial statements were available to be issued, and has determined that there is no subsequent event to report.